Lauren has written on emerging technologies and therapeutics since joining BioCentury in 2007. As Associate Editor, she guides BioCentury’s coverage of CRISPR and has written extensively on cell and gene therapies, the microbiome and gene control, as well as IP issues affecting the industry. Lauren holds a B.S.E. in Bioengineering from the University of Pennsylvania and an MBA from Temple University.
10:00 AM - 10:30 AM (EST)
Wednesday, February 17